Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients.docVIP

下载本文档

3
0
约5.21万字
约 14页
2017-05-16 发布于上海
举报

Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients.doc

Kochetal.CriticalCare2011,15:R63 /content/15/1/R63 RESEARCH OpenAccess Circulatingsolubleurokinaseplasminogen activatorreceptorisstablyelevatedduringthe firstweekoftreatmentintheintensivecareunit andpredictsmortalityincriticallyillpatients AlexanderKoch1,SebastianVoigt1,CarstenKruschinski2,EdouardSanson1,HannaDückers1,AndreasHorn1, ErayYagmur3,HenningZimmermann1,ChristianTrautwein1andFrankTacke1* Abstract Introduction:suPARisthesolubleformoftheurokinaseplasminogenactivatorreceptor(uPAR),whichis expressedinvariousimmunologicallyactivecells.HighsuPARserumconcentrationsaresuggestedtoreflectthe

您可能关注的文档

文档评论（0）

1亿VIP精品文档

更多 >

Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients.docVIP